Literature DB >> 6404641

Sodium valproate-induced hyperammonemia in the rat: role of the kidney.

J M Warter, M Imler, C Marescaux, G Chabrier, L Rumbach, G Micheletti, J Krieger.   

Abstract

The intravenous injection of sodium valproate (VPA) 200 mg/kg provoked in fasting rats a 100% increase in the arterial NH+4 concentration by the 10th min. The increase persisted at this level for at least 100 min. Simultaneous measurements of NH+4 and glutamine concentrations in the carotid artery, renal vein and suprahepatic vein showed that there were increases in the release of NH+4 and the uptake of glutamine by the kidney while the [NH+4] of suprahepatic venous blood remained stable. In binephrectomized rats injected with VPA, NH+4 levels did not change. These results suggest that the VPA-induced arterial hyperammonemia depended on the accelerated catabolism or possibly the reduced synthesis of glutamine by the kidneys. The liver of fasting rats does not seem to play a preponderant role in the VPA-induced hyperammonemia.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6404641     DOI: 10.1016/0014-2999(83)90327-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  10 in total

1.  Hyperammonaemia and hepatotoxicity during chronic valproate therapy: enhancement by combination with other antiepileptic drugs.

Authors:  R N Ratnaike; G J Schapel; G Purdie; R H Rischbieth; S Hoffmann
Journal:  Br J Clin Pharmacol       Date:  1986-07       Impact factor: 4.335

Review 2.  Advantages and limitations of the use of isolated kidney tubules in pharmacotoxicology.

Authors:  M F Chauvin; C Bolon; A Conjard; G Martin; B Ferrier; M Martin; C Michoudet; D Durozard; M C Laréal; C Gauthier; H Simonnet; M Elhamri; S Dugelay; B Joly; G Baverel
Journal:  Cell Biol Toxicol       Date:  1996-12       Impact factor: 6.691

Review 3.  Roles of renal ammonia metabolism other than in acid-base homeostasis.

Authors:  I David Weiner
Journal:  Pediatr Nephrol       Date:  2016-05-12       Impact factor: 3.714

4.  Valproic acid induction of coma in rats: synergism with NH4+ and pentobarbital.

Authors:  L Zieve; C Lyftogt
Journal:  Metab Brain Dis       Date:  1989-06       Impact factor: 3.584

5.  State of stupor from valproic acid during chronic treatment: case report.

Authors:  S Gentile; C Buffa; C Ravetti; I Sacerdote
Journal:  Ital J Neurol Sci       Date:  1991-04

Review 6.  Valproate-associated hepatotoxicity and its biochemical mechanisms.

Authors:  M J Eadie; W D Hooper; R G Dickinson
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Mar-Apr

7.  Hyperammonemia and hepatic status during valproate therapy.

Authors:  Rachna Agarwal; Sangeeta Sharma; Neelam Chhillar; Kiran Bala; Neeraj Singh; C B Tripathi
Journal:  Indian J Clin Biochem       Date:  2009-12-30

8.  Differential susceptibility of cholinergic and noncholinergic neurogenic responses to calcium channel blockers and low Ca2+ medium in rat urinary bladder.

Authors:  M B Bhat; S K Mishra; V Raviprakash
Journal:  Br J Pharmacol       Date:  1989-04       Impact factor: 8.739

Review 9.  Valproate hepatotoxicity syndrome: hypotheses of pathogenesis.

Authors:  J R Stephens; R H Levy
Journal:  Pharm Weekbl Sci       Date:  1992-06-19

Review 10.  Science review: carnitine in the treatment of valproic acid-induced toxicity - what is the evidence?

Authors:  Philippe E R Lheureux; Andrea Penaloza; Soheil Zahir; Mireille Gris
Journal:  Crit Care       Date:  2005-06-10       Impact factor: 9.097

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.